Literature DB >> 10149255

Two-dimensional echocardiography in myocardial amyloidosis.

E Picano1, B Pinamonti, E M Ferdeghini, L Landini, G Slavich, A Orlandini, C Marini, F Lattanzi, F Camerini.   

Abstract

Two-dimensional echocardiography is the best means of identifying early cardiac amyloid infiltration and gauging its subsequent progression. The early asymptomatic phase is characterized on echocardiography by a mild-to-moderate increase in left ventricular and/or right ventricular wall thicknesses. The distinctive combination of low electrocardiography voltage and increase in left ventricular mass on the echocardiogram, both compatible with substantial amyloid infiltration, is valuable in diagnosis and appears to indicate the severity of the disease. Other ancillary but common findings are left atrial dilatation, a small pericardial effusion, thickening of cardiac valves, papillary muscles, and interatrial septum. Finally, there is a peculiar texture of myocardial walls, with highly refractile areas that are typical, although not specific, of myocardial amyloidosis and can also be quantitatively described by digital image analysis techniques. The echocardiographic appearance of amyloidosis can closely mimic several other diseases. Asymmetric hypertrophy of the septum due to amyloid deposition may occur, simulating hypertrophic cardiomyopathy. The granular sparkling of myocardial walls is also found in myocarditis with severe fibrosis, and it is quite common in hypertrophic cardiomyopathy, as well as in other infiltrative diseases of the myocardium. It is not uncommon that the echocardiographic examination represents a turning point in the work-up of the patient, briskly orienting the clinician towards the correct diagnostic pathway. However, the likelihood of the cardiologist-echocardiographer to successfully and prospectively identify myocardial amyloidosis is substantially higher if all the clinical and electrocardiographic information is reviewed at the time of the echocardiographic examination.

Entities:  

Mesh:

Year:  1991        PMID: 10149255     DOI: 10.1111/j.1540-8175.1991.tb01395.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

2.  Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis.

Authors:  Zhongwei Cheng; Lin Kang; Zhuang Tian; Weiyun Chen; Wenjuan Guo; Jia Xu; Taibo Chen; Ligang Fang; Yong Zeng; Kang'an Cheng; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

3.  Persistent Cardiac Magnetic Resonance Imaging Features of Myocarditis Detected Months After COVID-19 Infection.

Authors:  Basel Abdelazeem; Mariem Borcheni; Saed Alnaimat; Sagar Mallikethi-Reddy; Abdulbaset Sulaiman
Journal:  Cureus       Date:  2021-04-01

Review 4.  The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.

Authors:  Shaun Khanna; Ivy Wen; Aditya Bhat; Henry H L Chen; Gary C H Gan; Faraz Pathan; Timothy C Tan
Journal:  Front Cardiovasc Med       Date:  2020-10-30

Review 5.  Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.

Authors:  Grigorios Korosoglou; Sorin Giusca; Florian André; Fabian Aus dem Siepen; Peter Nunninger; Arnt V Kristen; Norbert Frey
Journal:  Vasc Health Risk Manag       Date:  2021-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.